Rafferty Asset Management’s Arcus Biosciences RCUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $803K | Sell |
98,690
-13,636
| -12% | -$111K | ﹤0.01% | 797 |
|
|
2025
Q1 | $882K | Buy |
112,326
+34,644
| +45% | +$272K | ﹤0.01% | 765 |
|
|
2024
Q4 | $1.16M | Sell |
77,682
-6,512
| -8% | -$97K | ﹤0.01% | 763 |
|
|
2024
Q3 | $1.29M | Sell |
84,194
-11,598
| -12% | -$177K | ﹤0.01% | 742 |
|
|
2024
Q2 | $1.46M | Sell |
95,792
-243,875
| -72% | -$3.71M | 0.01% | 726 |
|
|
2024
Q1 | $6.41M | Buy |
339,667
+88,263
| +35% | +$1.67M | 0.02% | 409 |
|
|
2023
Q4 | $4.8M | Sell |
251,404
-41,304
| -14% | -$789K | 0.02% | 450 |
|
|
2023
Q3 | $5.25M | Sell |
292,708
-7,404
| -2% | -$133K | 0.03% | 377 |
|
|
2023
Q2 | $6.1M | Sell |
300,112
-110,880
| -27% | -$2.25M | 0.03% | 370 |
|
|
2023
Q1 | $7.5M | Buy |
410,992
+215,967
| +111% | +$3.94M | 0.05% | 262 |
|
|
2022
Q4 | $4.03M | Sell |
195,025
-33,616
| -15% | -$695K | 0.03% | 423 |
|
|
2022
Q3 | $5.98M | Buy |
228,641
+73,585
| +47% | +$1.92M | 0.06% | 293 |
|
|
2022
Q2 | $3.93M | Sell |
155,056
-6,498
| -4% | -$165K | 0.04% | 335 |
|
|
2022
Q1 | $5.1M | Buy |
161,554
+35,236
| +28% | +$1.11M | 0.03% | 388 |
|
|
2021
Q4 | $5.11M | Buy |
126,318
+43,988
| +53% | +$1.78M | 0.03% | 383 |
|
|
2021
Q3 | $2.87M | Sell |
82,330
-22,469
| -21% | -$784K | 0.02% | 507 |
|
|
2021
Q2 | $2.88M | Buy |
104,799
+13,397
| +15% | +$368K | 0.02% | 513 |
|
|
2021
Q1 | $2.57M | Buy |
91,402
+76,742
| +523% | +$2.16M | 0.02% | 562 |
|
|
2020
Q4 | $381K | Sell |
14,660
-55,687
| -79% | -$1.45M | ﹤0.01% | 749 |
|
|
2020
Q3 | $1.21M | Buy |
70,347
+54,521
| +345% | +$935K | 0.01% | 553 |
|
|
2020
Q2 | $392K | Buy |
+15,826
| New | +$392K | 0.01% | 768 |
|